Purdue Cancer Drug Platform (IMAGE) Purdue University Caption Herman O. Sintim, the Drug Discovery Professor of Chemistry in Purdue's Department of Chemistry, is a co-founder and chief scientific officer of KinaRx. A $1,999,998 SBIR Phase I/II grant from the National Institute of Cancer to KinaRx LLC, a Purdue University-affiliated startup, will help fast-track to human trials a novel platform aimed at treating relapse for certain diseases. Credit Herman O. Sintim/Purdue University Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.